Home
/
SAREPTA THERAPEUTICS, INC. (SRPT)
SAREPTA THERAPEUTICS, INC. (SRPT) Technical Analysis
Updated: 2026-05-01 03:20 UTC · Last close: 20.88 (+1.02%) · Support: 20.31 · Resistance: 27.44
SAREPTA THERAPEUTICS, INC. (SRPT) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
🚀 Bullish Trigger
a clean close above 27.44 would strengthen the upside continuation case.
Quick Read
From a roadmap perspective, the setup is boxed by support near 20.31 and resistance around 27.44.
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 20.31 and resistance around 27.44. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
📊 Technical Summary
The latest close for SAREPTA THERAPEUTICS, INC. (SRPT) came in at 20.88 (+1.02%). Price continues to hold above both the 50-day and 200-day moving averages, which keeps the broader trend structure constructive. 20-day momentum is running at -5.65%, with price is trading in the lower part of its roughly 52-week range (11.93–63.66), while ATR14 volatility is running near 4.43% of price. RSI(14) is 51.2, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging: pat_inverse_hs. Near-term structure is defined by support at 20.31 and resistance at 27.44. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 399.36M · Net income: -713.41M · EPS (basic): -1.80. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
SAREPTA THERAPEUTICS, INC.
Note: This is an algorithmic technical snapshot (not financial advice).